Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

IRLAB Therapeutics

1.59 SEK

+0.89 %

Less than 1K followers

IRLAB A

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for IRLAB Therapeutics

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue9.042.894.64.419.518.914.757.5
EBITDA-28.2-1.9-70.5-27.5-24.6-16.1-20.8-89.1
EBIT-29.4-3.0-75.1-28.6-25.7-17.2-21.9-93.4
EBIT-%-325.2 %-7.0 %-79.4 %-656.9 %-131.7 %-91.1 %-148.5 %-162.5 %
Profit before taxes-31.7-5.4-83.1-34.0-32.3-20.2-23.5-110.0
Net income-31.7-5.4-83.1-34.0-32.3-20.2-23.5-110.0
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.